Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$4.81B |
 |
TeleflexTFX |
-$40M |
 |
Universal Health ServicesUHS |
-$42M |
 |
HCA HealthcareHCA |
-$256M |
 |
ProgynyPGNY |
-$1.13B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| DEPPE MICHAEL J | Nov 6, 2024 | Sell | 5,189 | $154.7424 | $800,000 |
| DEPPE MICHAEL J | Nov 6, 2024 | Sell | 4,135 | $154.736 | $640,000 |
| DEPPE MICHAEL J | Nov 6, 2024 | Sell | 2,600 | $152.7115 | $400,000 |
| DEPPE MICHAEL J | Nov 6, 2024 | Sell | 2,400 | $153.9829 | $370,000 |
| DEPPE MICHAEL J | Nov 6, 2024 | Sell | 2,331 | $154.031 | $360,000 |
| DEPPE MICHAEL J | Nov 6, 2024 | Sell | 2,100 | $152.7029 | $320,000 |
| KUPPUSAMY KARTHIK | Oct 28, 2024 | Sell | 1,775 | $156.9156 | $280,000 |
| PREVOZNIK MICHAEL E | Aug 29, 2024 | Sell | 32,551 | $154.9727 | $5M |
| KUPPUSAMY KARTHIK | Aug 28, 2024 | Sell | 1,990 | $153.2612 | $300,000 |
| DELANEY MARK E | Jul 24, 2024 | Sell | 420 | $143.08 | $60,000 |
| KUPPUSAMY KARTHIK | Apr 29, 2024 | Sell | 1,760 | $140 | $250,000 |
| Doherty Catherine T. | Feb 29, 2024 | Sell | 1,187 | $125.88 | $150,000 |
| PREVOZNIK MICHAEL E | Feb 29, 2024 | Sell | 5,611 | $125.88 | $710,000 |
| Doherty Catherine T. | Feb 28, 2024 | Sell | 5,557 | $126.57 | $700,000 |
| Gregg Vicky B | Feb 23, 2024 | Sell | 2,500 | $126.6386 | $320,000 |
| PREVOZNIK MICHAEL E | Feb 22, 2024 | Sell | 661 | $126.14 | $83,000 |
| Doherty Catherine T. | Feb 22, 2024 | Sell | 821 | $126.14 | $100,000 |
| PREVOZNIK MICHAEL E | Mar 7, 2023 | Sell | 4,754 | $140.55 | $670,000 |
| Doherty Catherine T. | Mar 7, 2023 | Sell | 5,307 | $140.55 | $750,000 |
| Doherty Catherine T. | Mar 3, 2023 | Sell | 717 | $140.63 | $100,000 |
| PREVOZNIK MICHAEL E | Mar 2, 2023 | Sell | 593 | $138.54 | $82,000 |
| PREVOZNIK MICHAEL E | Feb 24, 2023 | Sell | 1,415 | $141.42 | $200,000 |
| Doherty Catherine T. | Feb 24, 2023 | Sell | 1,690 | $141.42 | $240,000 |
| RING TIMOTHY M | Dec 1, 2022 | Sell | 2,025 | $152.5 | $310,000 |
| Doherty Catherine T. | Nov 28, 2022 | Sell | 23,407 | $149.3737 | $3.5M |
| Doherty Catherine T. | Nov 28, 2022 | Sell | 17,358 | $148.9153 | $2.6M |
What's the latest insider transaction for Quest Diagnostics?
The most recent insider transaction for Quest Diagnostics was conducted by DEPPE MICHAEL J, who sold 5,189 shares on November 6, 2024 at a price of $154.74 per share.
Which insider has sold the most DGX stock over the last two years?
Doherty Catherine T. has sold the most DGX stock in the last 2 years, with a total value of $8.1M.
What is the total value of insider transactions for Quest Diagnostics (DGX) in the last 2 years?
The total value of insider transactions for Quest Diagnostics in the last 2 years is negative, amounting to -$19M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Quest Diagnostics' market confidence?
Over the last 2 years, insider transactions for Quest Diagnostics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
